Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study-Reference-Cited by-同舟云学术

Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study

Published:2017-03 Issue:2 Volume:84 Page:169-173
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Hoxha Ariela,Calligaro Antonia,Di Poi Emma,Peccatori Susanna,Favaro Maria,Del Ross Teresa,Ramonda Roberta,Grava Chiara,Raffeiner Bernd,Ravagni Paola,De Vita Salvatore,Ruffatti Amelia

Publisher

Elsevier BV

Subject

Rheumatology

Reference24 articles.

1. Safety issues of biologics in pregnant patients with rheumatic diseases;Østensen;Ann N Y Acad Sci,2014

2. Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review;Marchioni;World J Gastroenterol,2013

3. Biologic therapies and pregnancy: the story so far;Hyrich;Rheumatology (Oxford),2014

4. Are biologic drugs safe in pregnancy;Calligaro;Reumatismo,2014

5. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature;Berthelot;Joint Bone Spine,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Certolizumab pegol in the treatment of axial spondyloarthritis;Immunotherapy;2024-03-26

2. Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis;Therapeutic Advances in Musculoskeletal Disease;2023-01

3. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids;Rheumatology;2022-11-02

4. Therapy of psoriasis during pregnancy and breast‐feeding;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2022-05

5. Psoriasis‐Therapie während Schwangerschaft und Stillzeit;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2022-05